Brief: Isofol Medical Q2 EPS at SEK -0.05
22/08/2023 06:03
Aug 22 (Reuters) - Isofol Medical Q2 revenue SEK 0. * Q2 net income SEK -7.507 million * Q2 EPS SEK -0.05
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million
Brief: Isofol Medical Announces Bfarm Approval Of Optimized Phase Ib/Ii Study Design
Brief: Isofol Gets Gross Proceeds Of SEK 18.9 Mln In Connection With Exercise Of Warrants And Guarantee Commitments
Brief: Isofol Secures License Rights For Arfolitixorin In Autism